InvestSMART

Rhythm Biosciences Limited (ASX: RHY) - Announcements

Current share price for RHY : $0.097 0.005 (5.43%)+

ASX company news and announcements for Rhythm Biosciences Limited (RHY) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Rhythm Biosciences Limited (RHY) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Rhythm Biosciences Limited (RHY), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Rhythm Biosciences Limited (RHY)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$34 Rhythm Biosciences Signs Manufacturing Agreement 3 Feb 2026 8:45AM $0.150 $0.097 fallen by 35.33%
$34 Rhythm Biosciences secures strategic alliance with AGRF 29 Jan 2026 9:09AM $0.150 $0.097 fallen by 35.33%
$34 Rhythm Biosciences secures commercial alliance with CancerIQ 28 Jan 2026 9:23AM $0.140 $0.097 fallen by 30.71%
$34 Quarterly Activities Report and Appendix 4C 23 Jan 2026 9:33AM $0.160 $0.097 fallen by 39.38%
$34 Landmark Publication Validates ColoSTAT Clinical Performance 21 Jan 2026 9:26AM $0.150 $0.097 fallen by 35.33%
$34 Cleansing Notice 16 Jan 2026 2:58PM $0.150 $0.097 fallen by 35.33%
$34 Application for quotation of securities - RHY 16 Jan 2026 2:54PM $0.150 $0.097 fallen by 35.33%
$34 Notification of cessation of securities - RHY 14 Jan 2026 4:18PM $0.135 $0.097 fallen by 28.15%
$34 Launch of new Genetype CRC risk Test with ColoSTAT synergy 14 Jan 2026 9:25AM $0.120 $0.097 fallen by 19.17%
$34 Notification regarding unquoted securities - RHY 23 Dec 2025 4:31PM $0.120 $0.097 fallen by 19.17%
$34 Proposed issue of securities - RHY 19 Dec 2025 3:42PM $0.095 $0.097 risen by 2.11%
$34 Proposed issue of securities - RHY 18 Dec 2025 2:58PM $0.097 $0.097 fallen by 0%
$34 Rhythm Initiates Commercialisation of ColoSTAT 12 Dec 2025 9:26AM $0.083 $0.097 risen by 16.87%
$34 Departure of Chief Financial Officer 10 Dec 2025 3:11PM $0.082 $0.097 risen by 18.29%
$34 National Health Service of England Evaluation of ColoSTAT 10 Dec 2025 8:54AM $0.078 $0.097 risen by 24.36%
$34 RHY enters a US marketing partnership with Catch Bio 9 Dec 2025 8:30AM $0.079 $0.097 risen by 22.78%
$34 Change of Director's Interest Notice - David Atkins 3 Dec 2025 6:05PM $0.080 $0.097 risen by 21.25%
$34 Change of Director's Interest Notice - Gavin Fox-Smith 3 Dec 2025 6:03PM $0.080 $0.097 risen by 21.25%
$34 Change of Director's Interest Notice - Sue MacLeman 3 Dec 2025 6:02PM $0.080 $0.097 risen by 21.25%
$34 Notification of cessation of securities - RHY 3 Dec 2025 2:56PM $0.084 $0.097 risen by 15.48%
$34 Notification regarding unquoted securities - RHY 3 Dec 2025 1:47PM $0.084 $0.097 risen by 15.48%
$34 Cleansing Notice 3 Dec 2025 12:44PM $0.084 $0.097 risen by 15.48%
$34 Notification regarding unquoted securities - RHY 3 Dec 2025 12:14PM $0.084 $0.097 risen by 15.48%
$34 Notification regarding unquoted securities - RHY 2 Dec 2025 9:33AM $0.088 $0.097 risen by 10.23%
$34 Notification regarding unquoted securities - RHY 2 Dec 2025 9:26AM $0.088 $0.097 risen by 10.23%

51 - 75 of 639 results

Page 3 of 26

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.